{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:56:38Z","timestamp":1778104598221,"version":"3.51.4"},"reference-count":61,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T00:00:00Z","timestamp":1356566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Forensic Sciences"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperglycemia and new onset diabetes have been described with certain antipsychotic medications and some of the initial presentations are fatal diabetic ketoacidosis (<jats:styled-content style=\"fixed-case\">DKA<\/jats:styled-content>). We report 17 deaths due to<jats:styled-content style=\"fixed-case\">DKA<\/jats:styled-content>in psychiatric patients treated with second generation antipsychotic medications. Death certificates and toxicology data were searched for<jats:styled-content style=\"fixed-case\">DKA<\/jats:styled-content>and hyperglycemia. We reviewed the medical examiner records which included the autopsy, toxicology, police, and medical examiner investigators' reports. The decedents ranged in age from 32 to 57\u00a0years (average 48\u00a0years). There were 15 men and two women. The immediate cause of death was<jats:styled-content style=\"fixed-case\">DKA<\/jats:styled-content>in all. The psychiatric disorders included: 10 schizophrenia, three bipolar\/schizophrenia, two bipolar, and two major depression. The most frequent atypical antipsychotic medications found were quetiapine and olanzapine followed by risperidone. In 16 deaths, we considered the medication as primary or contributory to the cause of death.<\/jats:p>","DOI":"10.1111\/1556-4029.12044","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T17:01:32Z","timestamp":1356627692000},"page":"398-403","source":"Crossref","is-referenced-by-count":21,"title":["Fatal Diabetic Ketoacidosis and Antipsychotic Medication"],"prefix":"10.1111","volume":"58","author":[{"given":"Susan F.","family":"Ely","sequence":"first","affiliation":[{"name":"New York City Office of Chief Medical Examiner and Department of Forensic Medicine New York University School of Medicine 520 First Avenue New York NY 10016"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber R.","family":"Neitzel","sequence":"additional","affiliation":[{"name":"University of Arizona College of Medicine\u2010Phoenix 550 E. Van Buren Phoenix AZ 85004"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Gill","sequence":"additional","affiliation":[{"name":"New York City Office of Chief Medical Examiner and Department of Forensic Medicine New York University School of Medicine 520 First Avenue New York NY 10016"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,27]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1093"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0414"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105049039"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n1117"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505000909"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.nmd.0000165292.11527.16"},{"key":"e_1_2_5_8_1","first-page":"8","article-title":"Metabolic changes associated with antipsychotic use","volume":"6","author":"Lieberman JA","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.47.s87"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1709"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0517"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.02.017"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.533"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.09.003"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.11.002"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(05)80190-7"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1092"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401230109148955"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00331-0"},{"key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10401230209147399","article-title":"Phenomenology of and risk factors for new\u2010onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases","volume":"14","author":"Jin H","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.17.1448.34421"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00296.x"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00127-9"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1964.tb04953.x"},{"key":"e_1_2_5_25_1","first-page":"827","article-title":"Chlorpromazine induced diabetes","volume":"29","author":"Korenyi C","year":"1968","journal-title":"Dis Nerv Syst"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01628.x"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105049043"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-871245"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200405000-00009"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000218404.64619.52"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200501000-00007"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS15455J"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.17.1444.34423"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.9.844.35201"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19327"},{"issue":"1","key":"e_1_2_5_36_1","first-page":"1","article-title":"Second\u2010generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer JW","year":"2005","journal-title":"CNS Drugs"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000150224.38630.ae"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.1.19"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000142282.62336.e9"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0619"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.nmd.0000105996.62105.07"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1089\/152091503322250695"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.02.007"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-6-11"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000201496.23259.85"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0379-0738(82)90124-4"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.290"},{"key":"e_1_2_5_48_1","first-page":"278","article-title":"Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature","volume":"14","author":"Muench J","year":"2001","journal-title":"J Am Board Fam Pract"},{"issue":"27","key":"e_1_2_5_49_1","first-page":"10","article-title":"Clinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents","volume":"62","author":"Henderson DC","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0905"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0707"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2008.01712.x"},{"key":"e_1_2_5_53_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1520\/JFS10379J","article-title":"Sudden and unexpected deaths after acute onset of diabetes mellitus","volume":"22","author":"DiMaio V","year":"1971","journal-title":"J Forensic Sci"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.paf.0000127391.85007.f4"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.11.841.33629"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS10142J"},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2009.01011.x"},{"key":"e_1_2_5_58_1","first-page":"436","volume-title":"Trauma and disease in Spitz and Fisher's medicolegal investigation of death","author":"Adams VI","year":"2006"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2006.00222.x"},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/32.8.719"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-010-0509-6"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.2165\/00024677-200302020-00003"}],"container-title":["Journal of Forensic Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1556-4029.12044","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1556-4029.12044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T01:50:51Z","timestamp":1714787451000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1556-4029.12044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,27]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1111\/1556-4029.12044"],"URL":"https:\/\/doi.org\/10.1111\/1556-4029.12044","archive":["Portico"],"relation":{},"ISSN":["0022-1198","1556-4029"],"issn-type":[{"value":"0022-1198","type":"print"},{"value":"1556-4029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,27]]}}}